Curanex Pharmaceuticals Inc Common Stock (CURX) — Financial Flexibility Index
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Financial Flexibility Index of -49.40x as of September 2025. Free cash flow of $-9.19 Million (operating CF $-9.19 Million minus capex $0.00) represents -49% of total liabilities ($185.96K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Curanex Pharmaceuticals Inc Common Stock Financial Flexibility Index (2023–2024)
Historical Financial Flexibility Index trend for Curanex Pharmaceuticals Inc Common Stock across 2 annual periods. See Curanex Pharmaceuticals Inc Common Stock (CURX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Curanex Pharmaceuticals Inc Common Stock (2023–2024)
Year-by-year free cash flow to debt coverage for Curanex Pharmaceuticals Inc Common Stock. For the full company profile including market capitalisation, see market cap of Curanex Pharmaceuticals Inc Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -38.12x | $-555.57K | $-555.58K | $14.57K | ▼ -453377.3% |
| 2023 | -0.01x | $-120.00 | $-120.00 | $14.28K | — |